4.7 Article

The ubiquitin ligase NEDD4-2/NEDD4L regulates both sodium homeostasis and fibrotic signaling to prevent end-stage renal disease

期刊

CELL DEATH & DISEASE
卷 12, 期 4, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s41419-021-03688-7

关键词

-

资金

  1. National Health and Medical Research Council (NHMRC) of Australia Senior Principal Research Fellowship [GNT1103006]
  2. NHMRC [GNT1099307]
  3. University of South Australia
  4. Biomed City Project Grant from The Hospital Research Foundation (THRF)

向作者/读者索取更多资源

High Na+ diet exacerbates kidney damage in Nedd4-2 deficient mice, indicating progression towards end-stage renal disease with tubule dilation, extracellular matrix accumulation, and activation of multiple signaling pathways. Low Na+ diet rescues kidney disease in Nedd4-2 deficient mice by suppressing aberrant signaling pathways.
Kidney disease progression can be affected by Na+ abundance. A key regulator of Na+ homeostasis is the ubiquitin ligase NEDD4-2 and its deficiency leads to increased Na+ transport activity and salt-sensitive progressive kidney damage. However, the mechanisms responsible for high Na+ induced damage remain poorly understood. Here we show that a high Na+ diet compromised kidney function in Nedd4-2-deficient mice, indicative of progression toward end-stage renal disease. Injury was characterized by enhanced tubule dilation and extracellular matrix accumulation, together with sustained activation of both Wnt/beta -catenin and TGF-beta signaling. Nedd4-2 knockout in cortical collecting duct cells also activated these pathways and led to epithelial-mesenchymal transition. Furthermore, low dietary Na+ rescued kidney disease in Nedd4-2-deficient mice and silenced Wnt/beta -catenin and TGF-beta signaling. Our study reveals the important role of NEDD4-2-dependent ubiquitination in Na+ homeostasis and protecting against aberrant Wnt/beta -catenin/TGF-beta signaling in progressive kidney disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据